Close
Smartlab Europe
Inizio Ignite

Press Releases

BioIVT Launches HEPATOMUNE Kit to Facilitate Liver Toxicity and Inflammation Studies for Drug Discovery and Disease Research

BioIVT, a leading provider of research models and services for drug and diagnostic development, launched its HEPATOMUNE® kit, a long-term, stable, in vitro model for evaluating immune-related and inflammation-mediated liver injury. HEPATOMUNE cultures are composed of hepatocytes, stromal cells and...

Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment

Samsung Biologics (207940.KS) has entered into a partnership agreement with biotech Dinona, further expanding its CDO capabilities to provide a full scope of its development services from cell line development, process development, to non-clinical and clinical material manufacturing. Under...

Valicare GmbH extends GxP expertise

Valicare GmbH, a wholly owned subsidiary of Syntegon, now offers additional services along the entire product life cycle of pharmaceutically and biotechnologically produced drugs. A new focus is on consulting services for the transition of products from the development...

TraceLink Announces New Serialized Product Intelligence Solution

TraceLink, Inc., the leading digital platform company for the life science supply chain, introduced Serialized Product Intelligence™, a new cloud application that uses serialization data to provide actionable intelligence and drive operational excellence. As more compliance mandates continue to...

Approvals of COVID-19 biologics will put huge pressure on large-scale bioprocessing networks, according to CPhI Annual Report

The third part of the 2020 CPhI Annual Report – released during the second week of the CPhI Festival of Pharma (5-16 October, 2020) – predicts, that if approved, COVID vaccines and therapeutics will cause an impending biomanufacturing capacity...

Regeneron’s Antibody Cocktail REGN-EB3 is First FDA-Approved Treatment for Ebola

Regeneron Pharmaceuticals, Inc. announced that the U.S. FDA approved Inmazeb® (atoltivimab, maftivimab and odesivimab-ebgn) for the treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including newborns of mothers who have tested positive for the infection. “We...

TraceLink VRS Solution Implemented by Henry Schein Months Ahead of Deadline for DSCSA Saleable Returns Verification Requirement

TraceLink Inc., the leading digital platform company for the life sciences supply chain, announced that Henry Schein, the world’s largest provider of health care solutions to office-based dental and medical practitioners, has implemented TraceLink’s verification router service (VRS) solution....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »